Literature DB >> 16234236

Solution structure of the human immunodeficiency virus type 1 p6 protein.

Torgils Fossen1, Victor Wray, Karsten Bruns, Judhi Rachmat, Peter Henklein, Uwe Tessmer, Annette Maczurek, Patricia Klinger, Ulrich Schubert.   

Abstract

The human immunodeficiency virus type 1 p6 protein represents a docking site for several cellular and viral binding factors and fulfills major roles in the formation of infectious viruses. To date, however, the structure of this 52-amino acid protein, by far the smallest lentiviral protein known, either in its mature form as free p6 or as the C-terminal part of the Pr55 Gag polyprotein has not been unraveled. We have explored the high resolution structure and folding of p6 by CD and NMR spectroscopy. Under membranous solution conditions, p6 can adopt a helix-flexible helix structure; a short helix-1 (amino acids 14-18) is connected to a pronounced helix-2 (amino acids 33-44) by a flexible hinge region. Thus, p6 can be subdivided into two distinct structural and functional domains; helix-2 perfectly defines the region that binds to the virus budding factor AIP-1/ALIX, indicating that this structure is required for interaction with the endosomal sorting complex required for transport. The PTAP motif at the N terminus, comprising the primary late assembly domain, which is crucial for interaction with another cellular budding factor, Tsg101, does not exhibit secondary structure. However, the adjacent helix-1 may play an indirect role in the specific complex formation between p6 and the binding groove in Tsg101. Moreover, binding studies by NMR demonstrate that helix-2, which also comprises the LXXLF motif required for incorporation of the human immunodeficiency virus type 1 accessory protein Vpr into budding virions, specifically interacts with the Vpr binding region, indicating that under the specific solution conditions used for structure analysis, p6 adopted a functional conformation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16234236     DOI: 10.1074/jbc.M507375200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  Structural basis for viral late-domain binding to Alix.

Authors:  Sangho Lee; Anjali Joshi; Kunio Nagashima; Eric O Freed; James H Hurley
Journal:  Nat Struct Mol Biol       Date:  2007-02-04       Impact factor: 15.369

2.  Disparate Contributions of Human Retrovirus Capsid Subdomains to Gag-Gag Oligomerization, Virus Morphology, and Particle Biogenesis.

Authors:  Jessica L Martin; Luiza M Mendonça; Isaac Angert; Joachim D Mueller; Wei Zhang; Louis M Mansky
Journal:  J Virol       Date:  2017-06-26       Impact factor: 5.103

Review 3.  Protein intrinsic disorder as a flexible armor and a weapon of HIV-1.

Authors:  Bin Xue; Marcin J Mizianty; Lukasz Kurgan; Vladimir N Uversky
Journal:  Cell Mol Life Sci       Date:  2011-10-28       Impact factor: 9.261

4.  Matrix domain modulates HIV-1 Gag's nucleic acid chaperone activity via inositol phosphate binding.

Authors:  Christopher P Jones; Siddhartha A K Datta; Alan Rein; Ioulia Rouzina; Karin Musier-Forsyth
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

Review 5.  HIV-1 assembly, release and maturation.

Authors:  Eric O Freed
Journal:  Nat Rev Microbiol       Date:  2015-06-29       Impact factor: 60.633

6.  Distinct nucleic acid interaction properties of HIV-1 nucleocapsid protein precursor NCp15 explain reduced viral infectivity.

Authors:  Wei Wang; Nada Naiyer; Mithun Mitra; Jialin Li; Mark C Williams; Ioulia Rouzina; Robert J Gorelick; Zhengrong Wu; Karin Musier-Forsyth
Journal:  Nucleic Acids Res       Date:  2014-05-09       Impact factor: 16.971

7.  HIV-1 Vpr oligomerization but not that of Gag directs the interaction between Vpr and Gag.

Authors:  Joëlle V Fritz; Denis Dujardin; Julien Godet; Pascal Didier; Jan De Mey; Jean-Luc Darlix; Yves Mély; Hugues de Rocquigny
Journal:  J Virol       Date:  2009-11-18       Impact factor: 5.103

8.  Proline 35 of human immunodeficiency virus type 1 (HIV-1) Vpr regulates the integrity of the N-terminal helix and the incorporation of Vpr into virus particles and supports the replication of R5-tropic HIV-1 in human lymphoid tissue ex vivo.

Authors:  Jörg Votteler; Nicole Studtrucker; Stefan Sörgel; Jan Münch; Elke Rücker; Frank Kirchhoff; Bernhard Schick; Peter Henklein; Torgils Fossen; Karsten Bruns; Alok Sharma; Victor Wray; Ulrich Schubert
Journal:  J Virol       Date:  2007-06-06       Impact factor: 5.103

9.  Frequent and variable cytotoxic-T-lymphocyte escape-associated fitness costs in the human immunodeficiency virus type 1 subtype B Gag proteins.

Authors:  Christian L Boutwell; Jonathan M Carlson; Tien-Ho Lin; Aaron Seese; Karen A Power; Jian Peng; Yanhua Tang; Zabrina L Brumme; David Heckerman; Arne Schneidewind; Todd M Allen
Journal:  J Virol       Date:  2013-01-30       Impact factor: 5.103

10.  Solution structure of the equine infectious anemia virus p9 protein: a rationalization of its different ALIX binding requirements compared to the analogous HIV-p6 protein.

Authors:  Alok Sharma; Karsten Bruns; René Röder; Peter Henklein; Jörg Votteler; Victor Wray; Ulrich Schubert
Journal:  BMC Struct Biol       Date:  2009-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.